Treatment of the metabolic disturbances caused by antipsychotic drugs: Focus on potential drug interactions

The risk of excessive bodyweight gain, glucose dysregulation and hyperlipidaemia is differentially increased by conventional and atypical antipsychotic drugs. Switching or combining agents may be sufficient in some cases, but in many instances additional drug treatment will be required. This include...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical pharmacokinetics 2004, Vol.43 (1), p.1-15
Hauptverfasser:	BAPTISTA, Trino, NG YING KIN, N. M. K, BEAULIEU, Serge
Format:	Artikel
Sprache:	eng
Schlagworte:	Antipsychotic Agents - adverse effects Biological and medical sciences Drug Interactions Drug toxicity and drugs side effects treatment Humans Hypoglycemic Agents - adverse effects Hypoglycemic Agents - pharmacokinetics Hypoglycemic Agents - therapeutic use Hypolipidemic Agents - adverse effects Hypolipidemic Agents - pharmacokinetics Hypolipidemic Agents - therapeutic use Medical sciences Metabolic Syndrome - chemically induced Metabolic Syndrome - drug therapy Miscellaneous (drug allergy, mutagens, teratogens...) Neuropharmacology Pharmacology. Drug treatments Psycholeptics: tranquillizer, neuroleptic Psychology. Psychoanalysis. Psychiatry Psychopharmacology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!